MCVRX | VEVYX | MCVRX / VEVYX | |
Total Expense Ratio | 1.24 | 0.66 | 188% |
Annual Report Gross Expense Ratio | 1.25 | 0.66 | 189% |
Fund Existence | 21 years | 12 years | - |
Gain YTD | -12.072 | -11.002 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.1B | 15.9B | 95% |
Annual Yield % from dividends | 0.65 | 1.12 | 58% |
Returns for 1 year | -14.50 | -16.23 | 89% |
Returns for 3 years | -9.08 | -13.46 | 67% |
Returns for 5 years | 74.73 | 65.51 | 114% |
Returns for 10 years | 37.09 | 30.31 | 122% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SLYV | 70.45 | -3.26 | -4.42% |
SPDR® S&P 600 Small Cap Value ETF | |||
OVS | 27.78 | -1.36 | -4.68% |
Overlay Shares Small Cap Equity ETF | |||
PPH | 83.89 | -5.00 | -5.62% |
VanEck Pharmaceutical ETF | |||
ENZL | 40.13 | -2.59 | -6.06% |
iShares MSCI New Zealand ETF | |||
FIVA | 24.35 | -1.69 | -6.49% |
Fidelity International Value Factor ETF |